Skip to search formSkip to main contentSkip to account menu

MBC 215

Known as: MBC-215 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background: E17K is the most common activating AKT1 mutation and was shown to be a therapeutic target in this multipart Phase 1… 
2017
2017
Background: While great strides have been made in the treatment of estrogen receptor-positive (ER+) metastatic breast cancer (MBC… 
2010
2010
Introduction: S-1, a novel anticancer compound, contains tegafur, a prodrug of fluorouracil (FU), 5-chloro-2.4-dihydroxypyridine… 
2006
2006
Chiba, M., and Northover, J. 1988. Efficacy of new benzimidazole fungicides against sensitive and benomyl-resistant Botrytis…